NON INVASIVE HEMODYNAMIC MONITORING SYSTEM MARKET ANALYSIS

Regional Analysis

Technological advancements and initiatives are being adopted by industry players to boost the U.S. market. Also, rising usage of heart patient monitoring systems in Canada, high diabetes prevalence are likely to boost the market for non invasive hemodynamic monitoring system in North America. Asia-Pacific is expected to account for the second-largest share of the market. In the coming years, non invasive hemodynamic monitoring system market is expected to witness the highest growth in the Asia-Pacific region, with China, Japan, and India positioned as growth engines. In the Asia Pacific, especially in countries such as India and China, the demand for non invasive hemodynamic monitoring system is expected to gain significant traction. According to American Diabetic Association, around 60% of the world’s diabetic population lives in Asia. The prevalence of diabetes in India and China is 8.6% and 9.6% respectively. India is known as the diabetes capital of the world with more than 60 million diabetics in the country as of 2014.  Factors such as aging population in and high prevalence of diabetes in, increasing prevalence of cardiac diseases, and increase in healthcare spending by the population in emerging economies such as India, China, and Brazil, are driving the growth of the market in these regions.